Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

16 resultsUpdated October 23, 2026
1

Cost‐Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept

BioMed Research International 2021(1) (2021)

Ahmad Gholami; Jassem Azizpoor; Elham Aflaki; Mehdi Rezaee; Khosro Keshavarz

2

The Use of Expert Elicitation among Computational Modeling Studies in Health Research: A Systematic Review

Medical Decision Making 42(5) (2021)

Christopher J. Cadham; Marie Knoll; Luz María Sánchez‐Romero; K. Michael Cummings; Clifford E. Douglas; Alex C Liber; David Méndez; Rafael Meza; Ritesh Mistry; Aylin Sertkaya; Nargiz Travis; David Theodore Levy

3

A Systematic Review on Economic Evaluation Studies of Diagnostic and Therapeutic Interventions in the Middle East and North Africa

Applied Health Economics and Health Policy 20(3) (2021)

Mouaddh Abdulmalik Nagi; Pramitha Esha Nirmala Dewi; Montarat Thavorncharoensap; Sermsiri Sangroongruangsri

4

Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis

BMC Health Services Research 22(1) (2022)

Mehdi Rezaee; Mohammad Hossein Morowvat; Maryam Poursadeghfard; Armin Radgoudarzi; Khosro Keshavarz

5

QALY league table of Iran: a practical method for better resource allocation

Cost Effectiveness and Resource Allocation 19(1) (2021)

Reza Hashempour; Behzad Raei; Majid Safaei Lari; Nasrin Abolhasanbeigi Gallehzan; Ali Akbarisari

6

Cost-Effectiveness Analysis of Triptorelin, Goserelin, and Leuprolide in the Treatment of Patients With Metastatic Prostate Cancer: A Societal Perspective

Value in Health Regional Issues 42 (2024)

Mehdi Rezaee; Iman Karimzadeh; Amir Hashemi-Meshkini; Shahryar Zeighami; Mohammad Bazyar; Farhad Hosseinzadeh Lotfı; Khosro Keshavarz

7

Cost-Effectiveness Analysis of Pharmacogenomics-Guided Versus Standard Dosing of Warfarin in Patients with Mechanical Prosthetic Heart Valve

Iranian journal of pharmaceutical research 23(1) (2024)

Homa Hemati; Marzieh Nosrati; Mandana Hasanzad; Parham Rahmani; Soroush Fariman; Mohadese Sarabi; Sepideh Shirvani; Parham Sadeghipour; Shekoufeh Nikfar

8

Cost-utility Analysis of Second-generation Direct-acting Antivirals for Hepatitis C

Hepatitis Monthly 21(8) (2021)

Zahra Goudarzi; Abdollah Poursamad; Iman Karimzadeh; Nahid Jallaly; Khosro Keshavarz; Seyed Moayed Alavian

9

Cost-Benefit Analysis of Vaccination Strategies to Prevent Mother-to-Child Transmission of the Hepatitis B Virus Using a Markov Model Decision Tree

Frontiers in Public Health 10 (2022)

Nan Yang; Lei Lei; Yiyu Meng; Naitong Zhou; Lizheng Shi; Ming Hu

10

Decision-Analytical Modelling of Medicines in the Middle East: A Systematic Review of Economic Evaluation Studies

Applied Health Economics and Health Policy 23(4) (2025)

Zainab Abdali; Tuba Saygın Avşar; Sue M Jowett; Muslim Abbas Syed; Khalifa Elmusharaf; Louise Jackson

11

Budget impact analysis of glecaprevir/pibrentasvir treatment for hepatitis C in Iran: a modelling study

BMJ Open 15(9) (2025)

Mojtaba Jafari; Parisa Mehdizadeh; Khosro Keshavarz; Ehsan Teymourzadeh; Mohammad Ali Abyazi; Parsa Gholamreza Shirazi

12

Are Published Health Economic Models for Chronic Hepatitis B Appropriately Capturing the Benefits of HBsAg Loss? A Systematic Literature Review

PharmacoEconomics - Open 4(3) (2019)

P. Wigfield; Urbano Sbarigia; Mahmoud Hashim; Talitha Vincken; Bart M. S. Heeg

13

A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran

Cost Effectiveness and Resource Allocation 23(1) (2025)

Mojtaba Jafari; Parisa Mehdizadeh; Khosro Keshavarz; Ehsan Teymourzadeh; Mohammad Ali Abyazi; Seyed Moayed Alavian; Pouria Alijanpour

14

Cost-utility analysis of Edaravone compared to Riluzole in patients with amyotrophic lateral sclerosis (ALS) in Iran

Cost Effectiveness and Resource Allocation 24(1) (2026)

Habib Omranikhoo; Mehdi Rezaee; Ali Verdizadeh; Zahra Goudarzi; Mojtaba Jafari; Ahmad Gholami; Maryam Poursadeghfard; Khosro Keshavarz

15

Cost‐Effectiveness of Dimethyl Fumarate Versus Teriflunomide in Patients With Relapsing‐Remitting Multiple Sclerosis (RRMS) in Iran

Health Science Reports 9(4) (2026)

Maryam Poursadeghfard; Yasin Farjah; Mehdi Rezaee; Nastaran Momtahan; Mohammad Hossein Morowvat; Ahmad Gholami; Khosro Keshavarz